US2008081327A1PendingUtilityA1
Method for using division arrested cells in screening assays
Est. expirySep 20, 2022(expired)· nominal 20-yr term from priority
G01N 33/502G01N 33/5041C12Q 1/025G01N 33/5008G01N 33/5011G01N 33/6872
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Division arrested cells are used in screening assays to determine the effect of a substance of interest on the cells. The division arrested cells can be used in drug screening assays, signal transduction assays, and are especially useful in large scale, high throughput assays.
Claims
exact text as granted — not AI-modified1 . A method for determining effect of a substance of interest on a type of cell, comprising contacting the substance of interest to a sample of said type of cell, wherein the cells in said sample have had their division arrested, and determining a change in said sample of said cells following contact with said substance as a determination that said substance has an effect on said type of cell.
2 . The method of claim 1 , wherein said cell is a eukaryotic cell.
3 . The method of claim 1 , wherein said cell is a prokaryotic cell.
4 . The method of claim 1 , wherein division of said cell has been arrested during mitosis.
5 . The method of claim 1 wherein division of said cell has been arrested during meiosis.
6 . The method of claim 1 , wherein said cell has been transformed or transfected with a nucleic acid molecule which expresses a protein of interest.
7 . The method of claim 6 , wherein said cell has been transformed or transfected with a recombinant virus.
8 . The method of claim 1 , wherein said cell has been transformed or transfected with RNA.
9 . The method of claim 1 , wherein said cell has been transformed or transfected with an antisense nucleic acid molecule.
10 . The method of claim 1 , wherein said cell has been transduced with a protein, peptide, or protein containing molecule.
11 . The method of claim 1 , wherein said cell is an NIH3T3 cell.
12 . The method of claim 1 , said method comprising measuring induction of Ca 2+ immobilization.
13 . The method of claim 1 , wherein said cell has been transformed or transfected to produce 5HT2c.
14 . The method of claim 1 , wherein said cell expresses a G-protein coupled receptor.
15 . The method of claim 1 , wherein said cells express ion channels.
16 . The method of claim 14 , wherein said G-protein coupled receptor is muscaranic acetylcholine receptor.
17 . The method of claim 1 , wherein said cell is an HEK293 cell.
18 . The method of claim 1 , wherein said cell expresses a .beta.2 adrenergic receptor.
19 . The method of claim 1 , wherein said cell has been transformed or transfected with a nucleic acid molecule which encodes a reporter molecule.
20 . The method of claim 19 , wherein said nucleic acid molecule is activated via activation of a molecule expressed in said cell.
21 . The method of claim 19 , wherein said reporter molecule is luciferase, or green fluorescent protein.
22 . The method of claim 1 , said method comprising a competitive assay wherein said substance of interest is admixed with a compound known to affect to said cell, and determining any change in the known affect as a determination that said substance of interest affects said cell.
23 . A kit useful in screening a substance of interest to determine its affect on a cell type of interest, comprising a container means which holds a separate portion of each of: (i) a substance which arrests cell division of said cell; and, (ii) a substance known to interact with said cell and to provoke a known affect.
24 . The kit of claim 23 , further comprising a separate portion of (iii) a substance which affects a function other than cell division in said cell.Join the waitlist — get patent alerts
Track US2008081327A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.